1
|
Dicarlo M, Teti G, Verna G, Liso M, Cavalcanti E, Sila A, Raveenthiraraj S, Mastronardi M, Santino A, Serino G, Lippolis A, Sobolewski A, Falconi M, Chieppa M. Quercetin Exposure Suppresses the Inflammatory Pathway in Intestinal Organoids from Winnie Mice. Int J Mol Sci 2019; 20:ijms20225771. [PMID: 31744123 PMCID: PMC6888448 DOI: 10.3390/ijms20225771] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2019] [Revised: 11/04/2019] [Accepted: 11/14/2019] [Indexed: 12/18/2022] Open
Abstract
Inflammatory bowel diseases (IBDs) are chronic and relapsing immune disorders that result, or possibly originate, from epithelial barrier defects. Intestinal organoids are a new reliable tool to investigate epithelial response in models of chronic inflammation. We produced organoids from the ulcerative colitis murine model Winnie to explore if the chronic inflammatory features observed in the parental intestine were preserved by the organoids. Furthermore, we investigated if quercetin administration to in vitro cultured organoids could suppress LPS-induced inflammation in wild-type organoids (WT-organoids) and spontaneous inflammation in ulcerative colitis organoids (UC-organoids). Our data demonstrate that small intestinal organoids obtained from Winnie mice retain the chronic intestinal inflammatory features characteristic of the parental tissue. Quercetin administration was able to suppress inflammation both in UC-organoids and in LPS-treated WT-organoids. Altogether, our data demonstrate that UC-organoids are a reliable experimental system for investigating chronic intestinal inflammation and pharmacological responses.
Collapse
Affiliation(s)
- Manuela Dicarlo
- National Institute of Gastroenterology “S. de Bellis”, Institute of Research, 70013 Castellana Grotte (BA), Italy; (G.V.); (M.L.); (E.C.); (A.S.); (M.M.); (G.S.); (A.L.)
- Correspondence: (M.D.); (M.C.); Tel.: +39-089-233463 (M.C.)
| | - Gabriella Teti
- Department of Biomedical and Neuromotor Sciences-DBNS, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy; (G.T.); (M.F.)
| | - Giulio Verna
- National Institute of Gastroenterology “S. de Bellis”, Institute of Research, 70013 Castellana Grotte (BA), Italy; (G.V.); (M.L.); (E.C.); (A.S.); (M.M.); (G.S.); (A.L.)
| | - Marina Liso
- National Institute of Gastroenterology “S. de Bellis”, Institute of Research, 70013 Castellana Grotte (BA), Italy; (G.V.); (M.L.); (E.C.); (A.S.); (M.M.); (G.S.); (A.L.)
| | - Elisabetta Cavalcanti
- National Institute of Gastroenterology “S. de Bellis”, Institute of Research, 70013 Castellana Grotte (BA), Italy; (G.V.); (M.L.); (E.C.); (A.S.); (M.M.); (G.S.); (A.L.)
| | - Annamaria Sila
- National Institute of Gastroenterology “S. de Bellis”, Institute of Research, 70013 Castellana Grotte (BA), Italy; (G.V.); (M.L.); (E.C.); (A.S.); (M.M.); (G.S.); (A.L.)
| | - Sathuwarman Raveenthiraraj
- School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK; (S.R.); (A.S.)
| | - Mauro Mastronardi
- National Institute of Gastroenterology “S. de Bellis”, Institute of Research, 70013 Castellana Grotte (BA), Italy; (G.V.); (M.L.); (E.C.); (A.S.); (M.M.); (G.S.); (A.L.)
| | - Angelo Santino
- ISPA-CNR, Institute of Science of Food Production, C.N.R. Unit of Lecce, 73100 Lecce, Italy;
| | - Grazia Serino
- National Institute of Gastroenterology “S. de Bellis”, Institute of Research, 70013 Castellana Grotte (BA), Italy; (G.V.); (M.L.); (E.C.); (A.S.); (M.M.); (G.S.); (A.L.)
| | - Antonio Lippolis
- National Institute of Gastroenterology “S. de Bellis”, Institute of Research, 70013 Castellana Grotte (BA), Italy; (G.V.); (M.L.); (E.C.); (A.S.); (M.M.); (G.S.); (A.L.)
| | - Anastasia Sobolewski
- School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK; (S.R.); (A.S.)
| | - Mirella Falconi
- Department of Biomedical and Neuromotor Sciences-DBNS, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy; (G.T.); (M.F.)
| | - Marcello Chieppa
- National Institute of Gastroenterology “S. de Bellis”, Institute of Research, 70013 Castellana Grotte (BA), Italy; (G.V.); (M.L.); (E.C.); (A.S.); (M.M.); (G.S.); (A.L.)
- Department of Immunology and Cell Biology, European Biomedical Research Institute of Salerno (EBRIS), 84125 Salerno, Italy
- Correspondence: (M.D.); (M.C.); Tel.: +39-089-233463 (M.C.)
| |
Collapse
|
2
|
Bhushal S, Wolfsmüller M, Selvakumar TA, Kemper L, Wirth D, Hornef MW, Hauser H, Köster M. Cell Polarization and Epigenetic Status Shape the Heterogeneous Response to Type III Interferons in Intestinal Epithelial Cells. Front Immunol 2017; 8:671. [PMID: 28659914 PMCID: PMC5467006 DOI: 10.3389/fimmu.2017.00671] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2016] [Accepted: 05/23/2017] [Indexed: 11/13/2022] Open
Abstract
Type I and type III interferons (IFNs) are crucial components of the first-line antiviral host response. While specific receptors for both IFN types exist, intracellular signaling shares the same Jak-STAT pathway. Due to its receptor expression, IFN-λ responsiveness is restricted mainly to epithelial cells. Here, we display IFN-stimulated gene induction at the single cell level to comparatively analyze the activities of both IFN types in intestinal epithelial cells and mini-gut organoids. Initially, we noticed that the response to both types of IFNs at low concentrations is based on a single cell decision-making determining the total cell intrinsic antiviral activity. We identified histone deacetylase (HDAC) activity as a crucial restriction factor controlling the cell frequency of IFN-stimulated gene (ISG) induction upon IFN-λ but not IFN-β stimulation. Consistently, HDAC blockade confers antiviral activity to an elsewise non-responding subpopulation. Second, in contrast to the type I IFN system, polarization of intestinal epithelial cells strongly enhances their ability to respond to IFN-λ signaling and raises the kinetics of gene induction. Finally, we show that ISG induction in mini-gut organoids by low amounts of IFN is characterized by a scattered heterogeneous responsiveness of the epithelial cells and HDAC activity fine-tunes exclusively IFN-λ activity. This study provides a comprehensive description of the differential response to type I and type III IFNs and demonstrates that cell polarization in gut epithelial cells specifically increases IFN-λ activity.
Collapse
Affiliation(s)
- Sudeep Bhushal
- Research Group Model Systems for Infection and Immunity, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
| | - Markus Wolfsmüller
- Research Group Model Systems for Infection and Immunity, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
| | - Tharini A Selvakumar
- Research Group Model Systems for Infection and Immunity, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
| | - Lucas Kemper
- Research Group Model Systems for Infection and Immunity, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
| | - Dagmar Wirth
- Research Group Model Systems for Infection and Immunity, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
| | - Mathias W Hornef
- Institute for Medical Microbiology, RWTH Aachen University Hospital, Aachen, Germany
| | - Hansjörg Hauser
- Research Group Model Systems for Infection and Immunity, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
| | - Mario Köster
- Research Group Model Systems for Infection and Immunity, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
| |
Collapse
|